BlogTalkRadio uses cookies. By using our services, you're agreeing to our Cookies Policy. Got it

Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Communicating the Good, Bad & Ugly for CMOs and R&D Leaders in Biotech

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:8822205
archived

This discussion provides helpful approaches for Chief Medical Officers (CMOs) and other R&D leadership in biotech on how to communicate effectively in times of good, bad or unexpected news. Also discussed in this program are factors to evaluate for the discontinuation of a program. Dr Mark Weinberg, Chief Medical Officer and Managing Director of Halloran Consulting Group will be joined by Dr Lee AllenCMO, Argos Therapeutics to discuss strategic communication strategies CMOs/R&D leadership can utilize to effectively deliver unexpected or difficult news.

 More specifically:

  • How do you communicate successfully?
  • How does a CMO manage an unexpected realization?
  • Tips on being an advocate and skeptic for your programs
  • Flexibility and decision making with data
  • Scenario planning
  • Tips on communicating to the public
  • Evaluating factors for discontinuing a program
  • Rationalizing your portfolio? Who decides?

Guests:

Lee Allen, MD, PhD, CMOArgos Therapeutics

Mark Weinberg, MD, MBA, CMO and Managing Director, Halloran Consulting Group

Producer:

Valerie Bowling,  Executive Director, PharmaTalk Radio & The Conference Forum

Recommended Conference: The CMO and R&D Biotech Leadership Summit, Nov 14-15 in San Francisco. For more info:

http://theconferenceforum.org/conferences/rdbiotechleadershipsummit/overview/

 

Comments